MRCF has kickstarted a fifth fund to make early-stage investments in medical technologies from its network of member research institutions in Australia and New Zealand.

Queensland-founded Admedus Immunotherapies has fallen into administration after a deal with drug developer Constellation Therapeutics failed to materialise.

Uniseed, Carthona Capital and BridgeLane Group provided the funding for University of Sydney-founded Agerris, which is preparing to commercialise products including robotic farm hand systems.

QUT Bluebox has joined corporates Holland Insurance and Seven West Media in the second funding round for over-60s package holiday portal Starts at 60.

Oil and gas exploration company Woodside Energy was sufficiently intrigued in its earlier development pact with ECU-founded Sapien Cyber to purchase a 10% stake.

Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon Kids Institute with capital from an Australian government-backed initiative.

The multi-university venture fund led a $566,000 round for smart helmet developer Forcite, which has now collected $2m in total.

Multi-university-backed incubator Cicada Innovations has lost its chief executive and managing director Petra Andrén, who has decided to spend more time with her family.

Australian National University helped supply series A funding to scientific testing device manufacturer Liquid Instruments, which is led by a professor from the university’s College of Science.

Lidar technology developer Baraja has lured the support of Csiro's Innovation Fund as it pursues additional business for its autonomous vehicle perception system in the US and Asia.